Bayview Pharmacy's Hydrocortisone 3.75 mg Slow Release Capsules, formulated with Methocel E4M, offer a controlled and prolonged release profile. This formulation is designed to gradually release the active ingredient over an extended period, providing sustained therapeutic effects for conditions such as Atopic Dermatitis, Psoriasis, Seborrheic Dermatitis, Eczema, and Allergic Rhinitis. The reduced dosing frequency improves patient compliance.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Hydrocortisone 3.75 mg Slow Release Capsules is a potent medication primarily used to manage and treat a wide range of inflammatory and allergic conditions. As a corticosteroid, it functions by mitigating inflammation and suppressing the immune system's response. This particular formulation is designed to gradually release the active ingredient, hydrocortisone, over an extended period, ensuring a steady and consistent relief from symptoms.
This slow-release formulation is encapsulated with Methocel E4M, a controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication, providing sustained therapeutic effects. This slow-release mechanism reduces the frequency of dosing and improves patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
Hydrocortisone 3.75 mg Slow Release Capsules are indicated for the treatment of various inflammatory and allergic conditions. These include but are not limited to asthma, eczema, rheumatoid arthritis, and ulcerative colitis.
The medication is available in an easy-to-swallow capsule form and can be taken with or without food. It is crucial to adhere to the prescribed dosage by your healthcare provider. Avoid taking more or less than the recommended dose and consult your doctor before discontinuing the medication.
At Bayview Pharmacy, we prioritize providing our patients with the highest standard of care. If you have any queries or concerns about Hydrocortisone 3.75 mg Slow Release Capsules or any other medication, please feel free to contact us. We are here to assist you with your healthcare needs.
Hydrocortisone 3.75 mg Slow Release Capsules are a compounded formulation designed for the treatment of various inflammatory and allergic conditions. These include asthma, allergic rhinitis, atopic dermatitis, and rheumatoid arthritis. The capsules are also used in the management of specific endocrine disorders such as adrenal insufficiency and Cushing's syndrome. Hydrocortisone functions by reducing inflammation and suppressing the immune system.
The slow release formulation, made possible by the use of Methocel E4M, a controlled-release polymer, allows for a gradual release of the medication over an extended period. This provides a more consistent therapeutic effect, reduces the frequency of dosing, and improves patient compliance, especially for medications requiring a controlled and prolonged release profile.
Patients should be informed that hydrocortisone may cause side effects such as nausea, vomiting, stomach upset, headache, dizziness, and insomnia. It may also lead to an increase in blood pressure, necessitating regular monitoring. Hydrocortisone may interact with other medications, including anticoagulants, diuretics, and certain antibiotics, so patients should disclose all medications they are currently taking to their healthcare provider before starting hydrocortisone.
Prescribers should note that hydrocortisone may cause an increase in blood glucose levels, and may also lead to an increase in sodium and water retention. Regular monitoring of these parameters is recommended. As with patients, prescribers should also be aware of potential interactions between hydrocortisone and other medications, including anticoagulants, diuretics, and certain antibiotics.
If you have any questions about the use of Hydrocortisone 3.75 mg Slow Release Capsules, please do not hesitate to reach out for further information.
Hydrocortisone 3.75 mg Slow Release Capsules are a specialized medication designed to treat a range of inflammatory and allergic conditions. This medication functions by reducing inflammation and suppressing the immune system. The unique slow release formulation, made possible by the use of Methocel E4M, a controlled-release polymer, ensures a gradual release of the active ingredient over an extended period. This results in sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
These capsules are used to manage a variety of conditions, including but not limited to asthma, allergies, eczema, and rheumatoid arthritis. They can also be utilized in the treatment of certain types of cancer, such as lymphoma and leukemia. The slow release mechanism provides a more consistent level of relief, enhancing the effectiveness of the medication.
When using Hydrocortisone 3.75 mg Slow Release Capsules, it is crucial to adhere to the instructions provided by your healthcare provider. The dosage and frequency of administration will be determined based on the specific condition being treated. It is essential to take the medication as prescribed and not to exceed the recommended dosage to ensure optimal therapeutic benefits.
Like all medications, Hydrocortisone 3.75 mg Slow Release Capsules can cause side effects, which may include nausea, vomiting, headache, and dizziness. If you experience any of these or other side effects, it is important to contact your healthcare provider immediately for advice and potential adjustment of the medication regimen.
If you have any questions or concerns about Hydrocortisone 3.75 mg Slow Release Capsules, please do not hesitate to reach out to your healthcare provider or pharmacist. They are equipped with the necessary knowledge and expertise to provide you with accurate information and guidance regarding this medication.
Hydrocortisone 3.75 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is used in the formulation to ensure the medication is released gradually over a prolonged period, offering sustained therapeutic effects.
A slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
Due to its slow release formulation, the frequency of dosing for Hydrocortisone 3.75 mg Slow Release Capsules is typically less than that of regular medications. However, the exact dosing schedule should be determined by your healthcare provider based on your specific condition and response to therapy.
Hydrocortisone is a corticosteroid that can be used to treat a variety of conditions that involve inflammation. These can include certain types of arthritis, allergic reactions, skin diseases, and more. However, your healthcare provider should determine the appropriateness of this medication for your specific condition.
As with any medication, Hydrocortisone 3.75 mg Slow Release Capsules can have side effects. These can include nausea, heartburn, headache, dizziness, menstrual changes, trouble sleeping, increased sweating, and acne. If any of these effects persist or worsen, contact your healthcare provider immediately.
Before starting any new medication, including Hydrocortisone 3.75 mg Slow Release Capsules, you should always inform your healthcare provider about all the medications you are currently taking. This includes prescription medications, over-the-counter drugs, and herbal products.
If you miss a dose of Hydrocortisone 3.75 mg Slow Release Capsules, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
No, you should not stop taking Hydrocortisone 3.75 mg Slow Release Capsules abruptly without consulting your healthcare provider. Stopping the medication suddenly can lead to withdrawal symptoms.
Before taking Hydrocortisone 3.75 mg Slow Release Capsules during pregnancy, you should discuss the potential risks and benefits with your healthcare provider. It is important to consider both the mother's health and the health of the unborn baby.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth